To evaluate the effect of apamargadi tail gandush in tundikeri (tonsillitis).
Not Applicable
- Conditions
- Health Condition 1: J03- Acute tonsillitis
- Registration Number
- CTRI/2021/09/036723
- Lead Sponsor
- Dr ASHVINI ASHOKRAO PARKHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients having signs & symptoms of tonsillitis between ages 10 to 20 years irrespective of gender.
Exclusion Criteria
All patients having fever above 38 C (100.4F) Patients having critical conditions like Abscess, Cyst, diphtheria will be excluded.
Any major illness like T.B. and HTN
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of apamargadi tail gandush in TundikeriTimepoint: One & half years
- Secondary Outcome Measures
Name Time Method 1. To study in detail according to Ayurveda, the literature about tundikeri. <br/ ><br>2. To study in detail according to Ayurveda, the literature about tonsillitis. <br/ ><br>3. To study in detail according to Ayurveda, the literature about apamargadi tail gandush.Timepoint: one & half years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the anti-inflammatory effects of apamargadi tail gandush in acute tonsillitis?
How does apamargadi tail gandush compare to conventional corticosteroids in managing acute tonsillitis symptoms?
Are there specific biomarkers that correlate with improved outcomes following apamargadi tail gandush treatment in tonsillitis?
What are the potential adverse events associated with apamargadi tail gandush therapy for tonsillillar inflammation?
How might apamargadi tail gandush synergize with standard antibiotic regimens for Streptococcus pyogenes-induced tonsillitis?